Top Markets
Coin of the day
GeneReach Biotechnology Corp. GeneReach Biotechnology Corp.

GeneReach Biotechnology Corp.

4171
Classement en actions #27718
GeneReach Biotechnology Corp., a company based in Taichung, Taiwan, specializes... GeneReach Biotechnology Corp., a company based in Taichung, Taiwan, specializes in the development, production, and commercialization of advanced nucleic acid detection technologies. The company's extensive product line features essential laboratory instrumentation, including automated nucleic acid extraction systems, prep homogenization systems, and mini centrifuges. GeneReach also provides a wide range of reagents and consumables, such as human In Vitro Diagnostic (IVD) assays, specific iiPCR reagents, taco nucleic acid extraction reagents, IQ real quantitative systems, IQ2000 detection and prevention systems, and various research-grade reagents and supplies. Beyond its product offerings, GeneReach delivers comprehensive services. These encompass polymerase chain reaction (PCR) training programs, expert molecular diagnostic technical solutions, laboratory installation assistance, OEM/ODM contract manufacturing capabilities, and collaborative research services. Its innovative solutions cater to a diverse clientele, with applications spanning aquaculture, agriculture, food safety, human health, and the welfare of companion animals and livestock. GeneReach Biotechnology Corp. was established in 2004.
Prix de l'action
$0.54217343
Capitalisation boursière
$31.07M
Changement (1 jour)
-0.58%
Changement (1 an)
-19.09%
Pays
TW
Échange GeneReach Biotechnology Corp. (4171)

Catégorie

Le prix 4171 avec la capitalisation boursière de B
GeneReach Biotechnology Corp. GeneReach Biotechnology Corp.
4171
$0.54217343
Capitalisation boursière de GeneReach Biotechnology Corp.(4171)
Capitalisation boursière: $31.07M
En August 2026, GeneReach Biotechnology Corp. a une capitalisation boursière de $31.07M. Cela fait de GeneReach Biotechnology Corp. la 27718th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de GeneReach Biotechnology Corp. du 2012 au 2026
4171 par rapport au top 5 des plus populaires stocks
Prix pour 4171 L’actif B La capitalisation boursière de B Résultats
GeneReach Biotechnology Corp. GeneReach Biotechnology Corp.
$92,500.74 $31.07M
$5.301T +17,060,998.31%
GeneReach Biotechnology Corp. GeneReach Biotechnology Corp.
$80,861.52 $31.07M
$4.634T +14,914,227.09%
GeneReach Biotechnology Corp. GeneReach Biotechnology Corp.
$72,295.48 $31.07M
$4.143T +13,334,282.74%
GeneReach Biotechnology Corp. GeneReach Biotechnology Corp.
$62,634.96 $31.07M
$3.589T +11,552,468.69%
GeneReach Biotechnology Corp. GeneReach Biotechnology Corp.
$49,854.07 $31.07M
$2.857T +9,195,126.45%